Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26083005 | 1.00 | NAAA (0.42) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL26082997 | 0.98 | SMN1; SMN2 (0.42) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL6905751 | 0.92 | NAAA (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL30595294 | 0.92 | NAAA (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL30595298 | 0.92 | NAAA (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL755468 | 0.92 | NAAA (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL12382052 | 0.92 | NAAA (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| Hydrochloric Acid SCHEMBL5504535 | 0.91 | SMN1; SMN2 (0.49) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL316372 | 0.91 | SMN1; SMN2 (0.47) | NAAASMN1; SMN2GAAHTTMEN1 | |
| SCHEMBL20194422 | 0.88 | NAAA (0.42) | NAAASMN1; SMN2GAAHTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | HNRNPU, CBR1, CBR3 | NAAA 3769/4885SMN1; SMN2 2128/4885GAA 4805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.